HOLLISTON, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is spotlighting a range of its products and applications for preclinical life science research at SOT 2019, the 58th Annual Meeting of the Society of Toxicology and ToxExpo in Baltimore on March 10-14.
“DSI’s products are at the forefront of innovation and provide an impressive range of resources for researchers involved in toxicological studies,” said Jeffrey Duchemin, President and CEO of Harvard Bioscience. “Demonstrating our latest innovations at SOT, as well as participating in presentations, are excellent ways for us to interact with customers and communicate the broad scope and potential of our instrumentation to members of the scientific community.”
DSI will be sponsoring a session titled “Novel Approaches for Respiratory Measurement in Safety Pharmacology and Toxicology” on Tuesday, March 12 from 4:30-5:30 PM in Room 339 at the Baltimore Convention Center. During the session, Dr. Brian Roche from Charles River Laboratories and Dr. Benjamin Wong from the United States Army Medical Research Institute of Chemical Defense (USAMRICD) will discuss how DSI solutions assist in achieving study goals for safety pharmacology and the development of medical countermeasures for chemical agent exposure.
Also presented at the session will be interim results from an ongoing study of DSI’s newest digital implant, the PhysioTel™ Digital L11R. This implant monitors blood pressure, biopotential, temperature, respiratory volume, respiratory rate and activity while incorporating enhancements from the PhysioTel™ Digital platform. With PhysioTel™ Digital, animals can be socially housed in a wide range of enclosures and each implant is encoded with an individual animal ID, ensuring signal traceability and GLP compliance. In addition, researchers enjoy faster study setup and reduced risk of human error with automated implant configuration within the software. PhysioTel™ Digital implants also allow for remote programming and easy battery life management.
Additionally, DSI will be exhibiting the following at Booth #4034:
- Respiratory products: Whole body and head out plethysmography
- Telemetry: Large animal M series implants, large animal neuroscience implants L03 and L04, large animal glucose implant, L11R implant and more
- Inhalation tower and accessories for inhalation researchers
- Software: SEND solutions in Ponemah v5.31
- Services: Pre-implanted animals and other surgical services as well as data services
About Data Sciences International
Data Sciences International (DSI) provides a complete preclinical platform to assess physiological data for research ranging from basic, to drug discovery, and drug development. DSI is the leading provider of telemetry systems, pulmonary solutions, associated software platforms, and services. DSI is a subsidiary of Harvard Bioscience (Nasdaq:HBIO) a global developer, manufacturer, and marketer of a broad range of specialized products for life science research. For more information, please visit our website at www.datasci.com.
About Harvard Bioscience
Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of solutions to advance life science. Our products are sold to thousands of researchers in over 100 countries through our global sales organization, websites, catalogs, and through distributors including Thermo Fisher Scientific Inc., VWR, and other specialized distributors. We have sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Italy, Canada and China. For more information, please visit our website at www.harvardbioscience.com.
Contact:
Corey Manchester
Corporate Controller
Tel: 508 893 8999
Media Contact:
DGI Comm
Cheryl Schneider
212-825-3210
cschneider@dgicomm.com